Structures by: David B. I.
Total: 8
Tetrachlorobenzene - alpha polymorph
C6H2Cl4
Acta Crystallographica Section B (2006) 62, 2 287-295
a=3.8016(5)Å b=10.6369(15)Å c=9.4866(13)Å
α=92.072(2)° β=98.966(2)° γ=96.520(2)°
1,2,4,5-tetrachlorobenzene - alpha polymorph
C6Cl4D2
Acta Crystallographica Section B (2006) 62, 2 287-295
a=3.79900(10)Å b=10.62580(10)Å c=9.47938(7)Å
α=91.9780(9)° β=99.058(2)° γ=96.234(2)°
1,2,4,5-tetrachlorobenzene - beta polymorph
C6Cl4D2
Acta Crystallographica Section B (2006) 62, 2 287-295
a=3.78988(4)Å b=10.50328(5)Å c=9.56244(3)Å
α=90° β=99.7184(6)° γ=90°
1,2,4,5-tetrachlorobenzene - beta polymorph
C6Cl4D2
Acta Crystallographica Section B (2006) 62, 2 287-295
a=3.85595(5)Å b=10.61473(6)Å c=9.59283(4)Å
α=90° β=99.6884(7)° γ=90°
1,2,4,5-tetrachlorobenzene - beta polymorph
C6Cl4D2
Acta Crystallographica Section B (2006) 62, 2 287-295
a=3.81117(4)Å b=10.53867(4)Å c=9.57198(3)Å
α=90° β=99.7088(5)° γ=90°
1,2,4,5-tetrachlorobenzene - alpha polymorph
C6Cl4D2
Acta Crystallographica Section B (2006) 62, 2 287-295
a=3.76062(4)Å b=10.58794(5)Å c=9.44562(3)Å
α=92.4066(4)° β=98.6978(6)° γ=97.5893(6)°
Chlorothiazide
C7H6Cl1N3O4S2
Acta Crystallographica Section B (2008) 64, 1 101-107
a=4.8499(3)Å b=6.3694(4)Å c=8.9106(6)Å
α=74.4010(10)° β=83.8650(10)° γ=80.5240(10)°
Hydrochlorothiazide form II
C7H8Cl1N3O4S2
Acta Crystallographica Section B (2008) 64, 1 101-107
a=9.4855(3)Å b=8.3325(2)Å c=15.1201(4)Å
α=90° β=113.240(3)° γ=90°